Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H. Reisman Corporation was a specialized manufacturer and distributor of high-quality ingredients for the pharmaceutical, diagnostic, and nutritional industries. The company was particularly well-known for its expertise in fermentation technology, producing a wide range of enzymes, biochemicals, and active pharmaceutical ingredients (APIs). Based in New Jersey, it served as a critical supplier to global life science companies, providing both catalog products and custom contract manufacturing services. In 1995, the company was acquired by Marcor Development Corporation, which sought to integrate Reisman's fermentation capabilities into its own specialty chemical portfolio. Following subsequent industry consolidation, the legacy of H. Reisman's operations eventually became part of the Azelis Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H. Reisman.